SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001404644-24-000085
Filing Date
2024-08-09
Accepted
2024-08-09 07:31:06
Documents
53
Period of Report
2024-08-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ngne-20240809.htm   iXBRL 8-K 27946
2 EX-99.1 pressrelease9aug2024.htm EX-99.1 59357
3 EX-99.2 a202408_ngnecorporatepre.htm EX-99.2 42422
7 a202408_ngnecorporatepre001.jpg GRAPHIC 103716
8 a202408_ngnecorporatepre002.jpg GRAPHIC 282665
9 a202408_ngnecorporatepre003.jpg GRAPHIC 99235
10 a202408_ngnecorporatepre004.jpg GRAPHIC 68874
11 a202408_ngnecorporatepre005.jpg GRAPHIC 109587
12 a202408_ngnecorporatepre006.jpg GRAPHIC 131921
13 a202408_ngnecorporatepre007.jpg GRAPHIC 65234
14 a202408_ngnecorporatepre008.jpg GRAPHIC 36024
15 a202408_ngnecorporatepre009.jpg GRAPHIC 115091
16 a202408_ngnecorporatepre010.jpg GRAPHIC 108758
17 a202408_ngnecorporatepre011.jpg GRAPHIC 85504
18 a202408_ngnecorporatepre012.jpg GRAPHIC 87413
19 a202408_ngnecorporatepre013.jpg GRAPHIC 87556
20 a202408_ngnecorporatepre014.jpg GRAPHIC 81965
21 a202408_ngnecorporatepre015.jpg GRAPHIC 95752
22 a202408_ngnecorporatepre016.jpg GRAPHIC 125081
23 a202408_ngnecorporatepre017.jpg GRAPHIC 101765
24 a202408_ngnecorporatepre018.jpg GRAPHIC 156616
25 a202408_ngnecorporatepre019.jpg GRAPHIC 134108
26 a202408_ngnecorporatepre020.jpg GRAPHIC 129161
27 a202408_ngnecorporatepre021.jpg GRAPHIC 108289
28 a202408_ngnecorporatepre022.jpg GRAPHIC 38335
29 a202408_ngnecorporatepre023.jpg GRAPHIC 78612
30 a202408_ngnecorporatepre024.jpg GRAPHIC 89026
31 a202408_ngnecorporatepre025.jpg GRAPHIC 102504
32 a202408_ngnecorporatepre026.jpg GRAPHIC 106099
33 a202408_ngnecorporatepre027.jpg GRAPHIC 36137
34 a202408_ngnecorporatepre028.jpg GRAPHIC 84881
35 a202408_ngnecorporatepre029.jpg GRAPHIC 70174
36 a202408_ngnecorporatepre030.jpg GRAPHIC 29495
37 a202408_ngnecorporatepre031.jpg GRAPHIC 119936
38 a202408_ngnecorporatepre032.jpg GRAPHIC 82072
39 a202408_ngnecorporatepre033.jpg GRAPHIC 92907
40 a202408_ngnecorporatepre034.jpg GRAPHIC 112758
41 a202408_ngnecorporatepre035.jpg GRAPHIC 121918
42 a202408_ngnecorporatepre036.jpg GRAPHIC 77827
43 a202408_ngnecorporatepre037.jpg GRAPHIC 87560
44 image.jpg GRAPHIC 6748
  Complete submission text file 0001404644-24-000085.txt   5316950

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ngne-20240809.xsd EX-101.SCH 1907
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ngne-20240809_lab.xml EX-101.LAB 22548
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ngne-20240809_pre.xml EX-101.PRE 13050
55 EXTRACTED XBRL INSTANCE DOCUMENT ngne-20240809_htm.xml XML 2802
Mailing Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011
Business Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011 (877) 237-5020
Neurogene Inc. (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 980542593 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36327 | Film No.: 241190411
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)